View of EVALUATION THE RESULTS OF TREATMENT CDK4/6 INHIBITORS COMBINED WITH ENDOCRINE THERAPY IN FIRSTLINE TREATMENT OF RECURRENT METASTATIC HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE BREAST CANCER

Return to Article Details EVALUATION THE RESULTS OF TREATMENT CDK4/6 INHIBITORS COMBINED WITH ENDOCRINE THERAPY IN FIRSTLINE TREATMENT OF RECURRENT METASTATIC HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE BREAST CANCER Download Download PDF